Malignant melanoma presenting as an intrathymic tumor. A primary thymic melanoma?

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 1, 2000, Pages 130-134

  Alli, P M ^a   Crain, B J ^a   Heitmiller, R ^a   Argani, P ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOSOME; THORAX TUMOR; THYMOMA;

AGED; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOSOMES; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; RADIOGRAPHY, THORACIC; S100 PROTEINS; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033978626     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Nakleh RE, Wick MR, Rocamora A, Swanson PE, Dehner LP. Morphologic diversity in malignant melanomas. Am J Clin Pathol. 1990;93:731-740.
2. Zarbo RJ, Gown AM, Nagle RB, Visscher DW, Crissman JD. Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol. 1990;3:494-501.
3. Erlandson RA. Ultrastructural diagnosis of amelanotic malignant melanoma: aberrant melanosomes, myelin figures or lysosomes. Ultrastruct Pathol. 1987;11: 191-208.
4. Mazur MT, Katzenstein ALA. Metastatic melanoma: the spectrum of ultrastructural morphology. Ultrastruct Pathol. 1980;1:337-256.
5. Ho FCS, Ho JCI. Pigmented carcinoid tumor of the thymus. Histopathology. 1977;1:363-369.